Integrated stability and metabolomic investigation of new rifampicin and isoniazid co-loaded liposome against tuberculosis.

OBJECTIVES: This study aimed to develop and evaluate rifampicin (RIF) and isoniazid (INH) co-loaded liposome for sustained drug delivery to enhance therapeutic efficacy against tuberculosis (TB) and overcome challenges associated with prolonged treat…

Preview only. Read the full abstract at the source